As of 31 Dec 2025, 1 institutional investors reported holding 129,800 shares of XENON PHARMACEUTICALS INC - COM - Call.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 129,800 | $5,817,000 | +$5,817,000 | $44.82 | 1 |
| 2025 Q3 | $40.14 | 0 | |||
| 2025 Q2 | $31.30 | 0 | |||
| 2025 Q1 | $33.12 | 0 | |||
| 2024 Q4 | $39.18 | 0 | |||
| 2024 Q3 | $39.36 | 0 | |||
| 2024 Q2 | $38.99 | 0 | |||
| 2024 Q1 | $43.05 | 0 | |||
| 2023 Q4 | $46.06 | 0 | |||
| 2023 Q3 | $34.16 | 0 | |||
| 2023 Q2 | $38.50 | 0 | |||
| 2023 Q1 | $35.79 | 0 | |||
| 2022 Q4 | $39.43 | 0 | |||
| 2022 Q3 | $37.92 | 0 | |||
| 2022 Q2 | $30.26 | 0 | |||
| 2022 Q1 | $30.41 | 0 | |||
| 2021 Q4 | $31.24 | 0 | |||
| 2021 Q3 | $16.80 | 0 | |||
| 2021 Q2 | $18.04 | 0 | |||
| 2021 Q1 | $1714.29 | 0 | |||
| 2020 Q3 | $44.82 | 0 | |||
| 2020 Q2 | $1000.00 | 0 | |||
| 2020 Q1 | $1000.00 | 0 | |||
| 2019 Q4 | $12.92 | 0 | |||
| 2019 Q3 | $10.00 | 0 | |||
| 2019 Q2 | $10.00 | 0 | |||
| 2019 Q1 | $1000.00 | 0 | |||
| 2018 Q4 | $60.00 | 0 | |||
| 2018 Q3 | $1200.00 | 0 | |||
| 2018 Q2 | $800.00 | 0 |